Anthony Manning
Director/Board Member chez PALATIN TECHNOLOGIES, INC.
Fortune : 26 330 $ au 31/03/2024
Profil
Anthony M.
Manning is the founder of Institute For Biomedical Entrepreneurship, Inc. He currently holds the position of Independent Director at Palatin Technologies, Inc. since 2017, Independent Director at Monte Rosa Therapeutics, Inc. since 2023, and Principal at Manning Bio Worldwide LLC.
Previously, he worked as the Head of Research at Celgene Corp., Vice President & Head of Autoimmune Diseases Research at Biogen, Inc. from 2007 to 2011, Principal at Signal Pharmaceuticals, Inc., Vice President & Global Head of Inflammation at Roche Pharmaceuticals, Inc. from 2002 to 2007, Senior Vice President of Research at Momenta Pharmaceuticals, Inc., SVP of Research & Preclinical Development at Aileron Therapeutics, Inc. from 2011 to 2013, and Vice President at Pharmacia Corp.
from 2000 to 2002.
He obtained his doctorate degree from the University of Otago in 1990.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/09/2023 | 14 080 ( 0,09% ) | 26 330 $ | 31/03/2024 |
Postes actifs de Anthony Manning
| Sociétés | Poste | Début |
|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Director/Board Member | 07/09/2017 |
| MONTE ROSA THERAPEUTICS, INC. | Director/Board Member | 25/07/2023 |
| Institute For Biomedical Entrepreneurship, Inc. | Founder | - |
Anciens postes connus de Anthony Manning
| Sociétés | Poste | Fin |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/04/2011 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/08/2007 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 01/01/2002 |
| MOMENTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Anthony Manning
| University of Otago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| AILERON THERAPEUTICS, INC. | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Signal Pharmaceuticals, Inc.
 Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Signal Pharmaceuticals Inc is pioneering the discovery and development of small molecule therapeutics which regulate the transcription factors involved in the progression of a number of inflammatory, viral and neurological diseases. The core technology for the company's research was discovered in the laboratories of three of its founders, and has been licensed from the University of California and the Salk Institute. (SB) It was located in San Diego, CA. | Commercial Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| Institute For Biomedical Entrepreneurship, Inc. |
